Ademi & O'Reilly, LLP Investigates Whether Palomar Medical Technologies, Inc. Has Obtained a Fair Price in Its Sale to Cynosure, Inc.
MILWAUKEE, March 18, 2013 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of Palomar Medical Technologies, Inc. for possible breaches of fiduciary duty and other violations of state law in connection with the sale of Palomar to Cynosure, Inc.
Click here to learn how to join the action: http://www.ademilaw.com/case/palomar-medical-technologies-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Palomar's long-term financial outlook is very positive and yet Palomar shareholders will receive only the equivalent of $13.65 per share when some analysts have put a price target on Palomar shares of $14.50. Cynosure is well aware of Palomar's improving financial metrics and is purchasing Palomar at a substantial discount. The merger agreement unreasonably limits prospective bids for Palomar by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Palomar receive and accept a superior bid. Palomar insiders, their affiliates and other majority shareholders own significant voting stock of Palomar, and will receive millions of dollars as part of change of control arrangements, and therefore can unduly influence a sale of Palomar not necessarily in the best interests of non-insider shareholders. In light of these facts, our investigation centers on the conduct of Palomar's Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Palomar given its current financial condition and prospects.
If you own common stock in Palomar and wish to obtain additional information, please contact Guri Ademi either at email@example.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/palomar-medical-technologies-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Ademi & O'Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.com